Drug Profile
Research programme: therapeutic agents - Pharmagenesis
Alternative Names: AstraStim; NeurTriptin; WilVentLatest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Pharmagenesis
- Class Antianaemics; Antidementias; Antifibrotics; Antiparkinsonians; Antithrombotics; Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease; Amyotrophic lateral sclerosis; Anaemia; Idiopathic pulmonary fibrosis; Leucopenia; Obstructive airway disorders; Parkinson's disease; Severe acute respiratory syndrome; Thrombocytopenia
Most Recent Events
- 24 Aug 2023 Discontinued - Preclinical for Anaemia in USA (IV)
- 24 Aug 2023 Discontinued - Preclinical for Idiopathic pulmonary fibrosis in USA (IV)
- 24 Aug 2023 Discontinued - Preclinical for Leucopenia in USA (IV)